Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Magrath, I
   Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues
   EUROPEAN JOURNAL OF CANCER
   
   I. Magrath, "Editorial comment on detection of Epstein-Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues", EUR J CANC, 37(15), 2001, pp. 1812-1815
2. Gurbuxani, S; Arya, LS; Raina, V; Sazawal, S; Khattar, A; Magrath, I; Marie, JP; Bhargava, M
   Significance of MDR1, MRP1, GST pi and GST mu mRNA expression in acute lymphoblastic leukemia in Indian patients
   CANCER LETTERS
   
   S. Gurbuxani et al., "Significance of MDR1, MRP1, GST pi and GST mu mRNA expression in acute lymphoblastic leukemia in Indian patients", CANCER LETT, 167(1), 2001, pp. 73-83
3. Sazawal, S; Gurbuxani, S; Bhatia, K; Khattar, A; Raina, V; Arya, LS; Vats, T; Magrath, I; Bhargava, M
   Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement
   LEUKEMIA RESEARCH
   
   S. Sazawal et al., "Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement", LEUK RES, 25(8), 2001, pp. 693-698
4. Rao, CR; Franklin, J; Lalitha, N; Bhatia, K; O'Conor, G; Magrath, I
   Frequency of Epstein-Barr virus (EBV) association and p53 expression in childhood and adult Hodgkin's disease in India
   INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
   
   C.R. Rao et al., "Frequency of Epstein-Barr virus (EBV) association and p53 expression in childhood and adult Hodgkin's disease in India", INT J PED H, 6(6), 2000, pp. 377
5. Rao, CR; Gutierrez, MI; Bhatia, K; Fend, F; Franklin, J; Appaji, L; Gallo, G; O'Conor, G; Lalitha, N; Magrath, I
   Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries
   LEUKEMIA & LYMPHOMA
   
   C.R. Rao et al., "Association of Burkitt's lymphoma with the Epstein-Barr virus in two developing countries", LEUK LYMPH, 39(3-4), 2000, pp. 329
6. Gutierrez, MI; Kingma, DW; Sorbara, L; Tran, M; Raffeld, M; Jaffe, ES; Magrath, I; Bhatia, K
   Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients
   LEUKEMIA & LYMPHOMA
   
   M.I. Gutierrez et al., "Association of EBV strains, defined by multiple loci analyses, in non-Hodgkin lymphomas and reactive tissues from HIV positive and HIV negative patients", LEUK LYMPH, 37(3-4), 2000, pp. 425-429
7. Nerurkar, AY; Vijayan, P; Srinivas, V; Soman, CS; Dinshaw, KA; Advani, SH; Magrath, I; Bhatia, K; Naresh, KN
   Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis
   ANNALS OF ONCOLOGY
   
   A.Y. Nerurkar et al., "Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: Impact on pathogenesis", ANN ONCOL, 11(4), 2000, pp. 475-478
8. Naresh, KN; Johnson, J; Srinivas, V; Soman, CS; Saikia, T; Advani, SH; Badwe, RA; Dinshaw, KA; Muckaden, M; Magrath, I; Bhatia, K
   Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells
   ANNALS OF ONCOLOGY
   
   K.N. Naresh et al., "Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells", ANN ONCOL, 11(1), 2000, pp. 91-96
9. Sazawal, S; Bhatia, K; Gurbuxani, S; Arya, LS; Raina, V; Khattar, A; Vats, T; Magrath, I; Bhargava, M
   Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India
   LEUKEMIA RESEARCH
   
   S. Sazawal et al., "Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India", LEUK RES, 24(7), 2000, pp. 575-582
10. Gutierrez, MI; Hamdy, N; Bhatia, K; Bornkamm, G; Lenoir, G; Epelman, S; Magrath, I
    Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY
    
    M.I. Gutierrez et al., "Geographic variation in t(8;14) chromosomal breakpoint locations and EBV association in Burkitt's lymphoma", INT J PED H, 6(3), 1999, pp. 161-168
11. Sikora, K; Advani, S; Koroltchouk, V; Magrath, I; Levy, L; Pinedo, H; Schwartsmann, G; Tattersall, M; Yan, S
    Essential drugs for cancer therapy: A World Health Organization consultation
    ANNALS OF ONCOLOGY
    
    K. Sikora et al., "Essential drugs for cancer therapy: A World Health Organization consultation", ANN ONCOL, 10(4), 1999, pp. 385-390
12. Advani, S; Pal, S; Venzon, D; Adde, M; Kurkure, PK; Nair, CN; Sirohi, B; Banavali, SD; Hawaldar, R; Kolhatkar, BB; Vats, T; Magrath, I
    Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen
    ANNALS OF ONCOLOGY
    
    S. Advani et al., "Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen", ANN ONCOL, 10(2), 1999, pp. 167-176
13. Bhatia, K; Magrath, I
    EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma
    JOURNAL OF VIROLOGY
    
    K. Bhatia e I. Magrath, "EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma", J VIROLOGY, 73(8), 1999, pp. 7096-7096
14. Gutierrez, MI; Cherney, B; Hussain, A; Mostowski, H; Tosato, G; Magrath, I; Bhatia, K
    Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis
    CANCER RESEARCH
    
    M.I. Gutierrez et al., "Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis", CANCER RES, 59(3), 1999, pp. 696-703
15. Magrath, I; Bhatia, K
    Breast cancer: a new Epstein-Barr virus-associated disease?
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    I. Magrath e K. Bhatia, "Breast cancer: a new Epstein-Barr virus-associated disease?", J NAT CANC, 91(16), 1999, pp. 1349-1350
16. Inamdar, N; Kumar, SA; Banavali, SD; Advani, S; Magrath, I; Bhatia, K
    Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    N. Inamdar et al., "Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India", INT J ONCOL, 13(6), 1998, pp. 1319-1322
17. ADDE M; SHAD A; VENZON D; ARNDT C; GOOTENBERG J; NEELY J; NIEDER M; OWEN W; SEIBEL N; WILSON W; HORAK ID; MAGRATH I
    ADDITIONAL CHEMOTHERAPY AGENTS IMPROVE TREATMENT OUTCOME FOR CHILDRENAND ADULTS WITH ADVANCED B-CELL LYMPHOMAS
    Seminars in oncology
    
    M. Adde et al., "ADDITIONAL CHEMOTHERAPY AGENTS IMPROVE TREATMENT OUTCOME FOR CHILDRENAND ADULTS WITH ADVANCED B-CELL LYMPHOMAS", Seminars in oncology, 25(2), 1998, pp. 33-39
18. SHAD A; MUELLER B; ADDE M; AVILA N; SLEASMAN J; PIZZO P; MAGRATH I
    RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKINS-LYMPHOMAS (NHLS)
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    A. Shad et al., "RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKINS-LYMPHOMAS (NHLS)", Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 150-150
19. VENKATESH H; MEZACORIA C; LOPEZCORELLA E; RIDAURASANZ C; OCONOR G; LUNA RR; BHATIA K; MAGRATH I
    EXPRESSION OF P53 IN PEDIATRIC LYMPHOMAS FROM MEXICO - RELATION TO HISTOLOGY AND IMMUNOPHENOTYPE
    International journal of oncology
    
    H. Venkatesh et al., "EXPRESSION OF P53 IN PEDIATRIC LYMPHOMAS FROM MEXICO - RELATION TO HISTOLOGY AND IMMUNOPHENOTYPE", International journal of oncology, 11(3), 1997, pp. 477-480
20. ADVANI S; PAI S; ADDE M; VAIDYA S; VATS T; NARESH K; KURKURE PA; NAIR CN; VENZON D; MAGRATH I
    PRELIMINARY-REPORT OF AN INTENSIFIED, SHORT-DURATION CHEMOTHERAPY PROTOCOL FOR THE TREATMENT OF PEDIATRIC NON-HODGKINS-LYMPHOMA IN INDIA
    Annals of oncology
    
    S. Advani et al., "PRELIMINARY-REPORT OF AN INTENSIFIED, SHORT-DURATION CHEMOTHERAPY PROTOCOL FOR THE TREATMENT OF PEDIATRIC NON-HODGKINS-LYMPHOMA IN INDIA", Annals of oncology, 8(9), 1997, pp. 893-897
21. GUTIERREZ MI; BHATIA K; CHERNEY B; CAPELLO D; GAIDANO G; MAGRATH I
    INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA
    Annals of oncology
    
    M.I. Gutierrez et al., "INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA", Annals of oncology, 8(10), 1997, pp. 987-994
22. SHAD A; MAGRATH I
    NON-HODGKINS-LYMPHOMA
    The Pediatric clinics of North America
    
    A. Shad e I. Magrath, "NON-HODGKINS-LYMPHOMA", The Pediatric clinics of North America, 44(4), 1997, pp. 863
23. MAGRATH I
    LIMITING THERAPY FOR LIMITED CHILDHOOD NON-HODGINS-LYMPHOMA
    The New England journal of medicine
    
    I. Magrath, "LIMITING THERAPY FOR LIMITED CHILDHOOD NON-HODGINS-LYMPHOMA", The New England journal of medicine, 337(18), 1997, pp. 1304-1306
24. GUTIERREZ MI; CHERNEY B; HUSSAIN A; MAGRATH I; BHATIA K
    EXPRESSION OF DEATH INDUCING GENES AND THE ACTIVATION OF DEATH INDUCING PATHWAY IN BURKITTS-LYMPHOMA
    Blood
    
    M.I. Gutierrez et al., "EXPRESSION OF DEATH INDUCING GENES AND THE ACTIVATION OF DEATH INDUCING PATHWAY IN BURKITTS-LYMPHOMA", Blood, 90(10), 1997, pp. 335-335
25. GUTIERREZ MI; CAPELLO D; CHERNEY B; GAIDANO G; MAGRATH I; BHATIA K
    INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA
    Blood
    
    M.I. Gutierrez et al., "INTRACLONAL MOLECULAR HETEROGENEITY SUGGESTS A HIERARCHY OF PATHOGENETIC EVENTS IN BURKITTS-LYMPHOMA", Blood, 90(10), 1997, pp. 336-336
26. SAZAWAL S; BHATIA K; GURBUXANI S; ARYA LS; RAINA V; VATS T; MAGRATH I; BHARGAVA M
    SIGNIFICANCE OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TCR) GENE REARRANGEMENTS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN INDIA
    Blood
    
    S. Sazawal et al., "SIGNIFICANCE OF IMMUNOGLOBULIN (IG) AND T-CELL RECEPTOR (TCR) GENE REARRANGEMENTS IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN INDIA", Blood, 90(10), 1997, pp. 823-823
27. MAGRATH I; ADDE M; SHAD A; VENZON D; SEIBEL N; NEELEY J; GOOTENBERG J; ARNDT C; NIEDER M; OWEN W; WILSON W; HORAK I
    RELATIVE EFFICACY OF G AND GM-CSFS IN AMELIORATING TOXICITY IN AN INTENSIVE TREATMENT PROTOCOL FOR ADVANCED, DIFFUSE B-CELL NHLS, PREDOMINANTLY SMALL NONCLEAVED CELL LYMPHOMAS
    Blood
    
    I. Magrath et al., "RELATIVE EFFICACY OF G AND GM-CSFS IN AMELIORATING TOXICITY IN AN INTENSIVE TREATMENT PROTOCOL FOR ADVANCED, DIFFUSE B-CELL NHLS, PREDOMINANTLY SMALL NONCLEAVED CELL LYMPHOMAS", Blood, 90(10), 1997, pp. 847-847
28. RAO CR; GUTIERREZ MI; HUSSAIN A; MAGRATH I; BHATIA K
    CONSTITUTIVE EXPRESSION OF FAS-LIGAND IN B-CELL LYMPHOMAS
    Blood
    
    C.R. Rao et al., "CONSTITUTIVE EXPRESSION OF FAS-LIGAND IN B-CELL LYMPHOMAS", Blood, 90(10), 1997, pp. 1084-1084
29. JUDDE JG; SPANGLER G; MAGRATH I; BHATIA K
    USE OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 IN TARGETED THERAPY OF EBV-ASSOCIATED NEOPLASIA
    Human gene therapy
    
    J.G. Judde et al., "USE OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-1 IN TARGETED THERAPY OF EBV-ASSOCIATED NEOPLASIA", Human gene therapy, 7(5), 1996, pp. 647-653
30. KHALED HM; ELMAWLA NG; ELSAID A; HAMZA MR; GAAFAR R; ELATTAR I; ABURABIA A; MAGRATH I
    COMBINATION CHEMOTHERAPY FOR ADVANCED BILHARZIAL BLADDER-CARCINOMA
    Annals of oncology
    
    H.M. Khaled et al., "COMBINATION CHEMOTHERAPY FOR ADVANCED BILHARZIAL BLADDER-CARCINOMA", Annals of oncology, 7(7), 1996, pp. 751-754
31. MAGRATH I; ADDE M; SHAD A; VENZON D; SEIBEL N; GOOTENBERG J; NEELY J; ARNDT C; NIEDER M; JAFFE E; WITTES RA; HORAK ID
    ADULTS AND CHILDREN WITH SMALL NON-CLEAVED-CELL LYMPHOMA HAVE A SIMILAR EXCELLENT OUTCOME WHEN TREATED WITH THE SAME CHEMOTHERAPY REGIMEN
    Journal of clinical oncology
    
    I. Magrath et al., "ADULTS AND CHILDREN WITH SMALL NON-CLEAVED-CELL LYMPHOMA HAVE A SIMILAR EXCELLENT OUTCOME WHEN TREATED WITH THE SAME CHEMOTHERAPY REGIMEN", Journal of clinical oncology, 14(3), 1996, pp. 925-934
32. KINGMA DW; SHAD A; TSOKOS M; FEST T; OTSUKI T; FREKKO K; WERNER E; WERNER A; MAGRATH I; RAFFELD M; JAFFE ES
    EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED SMOOTH-MUSCLE TUMOR ARISING IN A POSTTRANSPLANT PATIENT TREATED SUCCESSFULLY FOR 2 PT-EBV-ASSOCIATED LARGE-CELL LYMPHOMAS - CASE-REPORT
    The American journal of surgical pathology
    
    D.W. Kingma et al., "EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED SMOOTH-MUSCLE TUMOR ARISING IN A POSTTRANSPLANT PATIENT TREATED SUCCESSFULLY FOR 2 PT-EBV-ASSOCIATED LARGE-CELL LYMPHOMAS - CASE-REPORT", The American journal of surgical pathology, 20(12), 1996, pp. 1511-1519
33. GUTIERREZ MI; RAJ A; SPANGLER G; GUERRERO I; JUDDE JG; MAGRATH I; BHATIA K
    SEQUENCE VARIATIONS IN EBNA-1 SPECIFIC FOR B-CELL OR T-CELL LYMPHOMASMAY UNDERLIE THE PATHOGENETIC ROLE OF EBV IN LYMPHOMAGENESIS
    Blood
    
    M.I. Gutierrez et al., "SEQUENCE VARIATIONS IN EBNA-1 SPECIFIC FOR B-CELL OR T-CELL LYMPHOMASMAY UNDERLIE THE PATHOGENETIC ROLE OF EBV IN LYMPHOMAGENESIS", Blood, 88(10), 1996, pp. 823-823
34. KURKURE P; PAI S; VAIDYA S; KAPOOR G; NAIR C; GOPAL R; SAIKIA T; PARIKH P; PAI V; MAGRATH I; ADVANI S
    IMPACT OF IMPROVED SUPPORTIVE CARE ON TREATMENT OUTCOME IN ACUTE LYMPHOBLASTIC-LEUKEMIA - AN INDIAN EXPERIENCE
    European journal of cancer
    
    P. Kurkure et al., "IMPACT OF IMPROVED SUPPORTIVE CARE ON TREATMENT OUTCOME IN ACUTE LYMPHOBLASTIC-LEUKEMIA - AN INDIAN EXPERIENCE", European journal of cancer, 31A, 1995, pp. 1241-1241
35. HAMDY N; BHATIA K; SHAKER H; KAMEL A; ELMAWLA NG; ABOUENEIN M; YASSIN D; ELSHARKAWY N; MAGRATH I
    MOLECULAR EPIDEMIOLOGY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN EGYPT
    Leukemia
    
    N. Hamdy et al., "MOLECULAR EPIDEMIOLOGY OF ACUTE LYMPHOBLASTIC-LEUKEMIA IN EGYPT", Leukemia, 9(1), 1995, pp. 194-202
36. MAGRATH I
    BONE-MARROW TRANSPLANTATION
    Lancet
    
    I. Magrath, "BONE-MARROW TRANSPLANTATION", Lancet, 346(8966), 1995, pp. 59-60
37. MAGRATH I
    BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - A LAME STALKING HORSE FOR USE OF HIGH-TECHNOLOGY MEDICAL-CARE
    Lancet
    
    I. Magrath, "BONE-MARROW TRANSPLANTATION FOR LEUKEMIA - A LAME STALKING HORSE FOR USE OF HIGH-TECHNOLOGY MEDICAL-CARE", Lancet, 345(8950), 1995, pp. 601-602
38. BHATIA K; FAN SJ; SPANGLER G; WEINTRAUB M; OCONNOR PM; JUDDE JG; MAGRATH I
    A MUTANT P21 CYCLIN-DEPENDENT KINASE INHIBITOR ISOLATED FROM A BURKITTS-LYMPHOMA
    Cancer research
    
    K. Bhatia et al., "A MUTANT P21 CYCLIN-DEPENDENT KINASE INHIBITOR ISOLATED FROM A BURKITTS-LYMPHOMA", Cancer research, 55(7), 1995, pp. 1431-1435
39. ANWAR N; KINGMA DW; BLOCH AR; MOURAD M; RAFFELD M; FRANKLIN J; MAGRATH I; ELBOLKAINY N; JAFFE ES
    THE INVESTIGATION OF EPSTEIN-BARR VIRAL SEQUENCES IN 41 CASES OF BURKITTS-LYMPHOMA FROM EGYPT - EPIDEMIOLOGIC CORRELATIONS
    Cancer
    
    N. Anwar et al., "THE INVESTIGATION OF EPSTEIN-BARR VIRAL SEQUENCES IN 41 CASES OF BURKITTS-LYMPHOMA FROM EGYPT - EPIDEMIOLOGIC CORRELATIONS", Cancer, 76(7), 1995, pp. 1245-1252
40. NARESH K; BHATIA K; VENKATESH H; SOMAN C; PAI S; ADVANI S; ADDE M; MAGRATH I
    THE MAJORITY OF PRIMARY LYMPHOBLASTIC LYMPHOMAS EXPRESS P53
    Blood
    
    K. Naresh et al., "THE MAJORITY OF PRIMARY LYMPHOBLASTIC LYMPHOMAS EXPRESS P53", Blood, 86(10), 1995, pp. 1349-1349
41. VENKATESH C; BHATIA K; LOPEZCORELLA E; MESA C; RIVERALUNA R; OCONNOR G; MAGRATH I
    P53 EXPRESSION IN CHILDHOOD NON-HODGKINS-LYMPHOMA IN MEXICO IS MORE FREQUENT IN B-CELL NONLYMPHOBLASTIC LYMPHOMAS THAN IN LYMPHOBLASTIC LYMPHOMAS
    Blood
    
    C. Venkatesh et al., "P53 EXPRESSION IN CHILDHOOD NON-HODGKINS-LYMPHOMA IN MEXICO IS MORE FREQUENT IN B-CELL NONLYMPHOBLASTIC LYMPHOMAS THAN IN LYMPHOBLASTIC LYMPHOMAS", Blood, 86(10), 1995, pp. 1362-1362
42. GUTIERREZ MI; BHATIA K; DIEZ B; MURIEL FS; EPELMAN S; DEANDREAS ML; HUPPI K; MAGRATH I
    PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS
    International journal of oncology
    
    M.I. Gutierrez et al., "PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS", International journal of oncology, 4(3), 1994, pp. 567-571
43. BHATIA K; SPANGLER G; HUPPI K; SIWARSKI D; MAGRATH I
    LOSS OF WILD-TYPE C-MYC IN BURKITTS LYMPHOMAS
    Journal of cellular biochemistry
    
    K. Bhatia et al., "LOSS OF WILD-TYPE C-MYC IN BURKITTS LYMPHOMAS", Journal of cellular biochemistry, 1994, pp. 198-198
44. JAIN VK; SEEM N; GESELOVITZ D; NECKERS D; MAGRATH I
    INHIBITION OF IMMUNOGLOBULIN HEAVY-CHAIN (MU)-ENHANCER ACTIVITY BY A DNA OLIGOMER DIRECTED AT THE (MU)E4-MOTIF INHIBITS C-MYC TRANSCRIPTIONIN BURKITTS-LYMPHOMA
    Experimental hematology
    
    V.K. Jain et al., "INHIBITION OF IMMUNOGLOBULIN HEAVY-CHAIN (MU)-ENHANCER ACTIVITY BY A DNA OLIGOMER DIRECTED AT THE (MU)E4-MOTIF INHIBITS C-MYC TRANSCRIPTIONIN BURKITTS-LYMPHOMA", Experimental hematology, 22(8), 1994, pp. 718-718
45. FAN SJ; ELDEIRY WS; BAE I; FREEMAN J; JONDLE D; BHATIA K; FORNACE AJ; MAGRATH I; KOHN KW; OCONNOR PM
    P53 GENE-MUTATIONS ARE ASSOCIATED WITH DECREASED SENSITIVITY OF HUMANLYMPHOMA-CELLS TO DNA-DAMAGING AGENTS
    Cancer research
    
    S.J. Fan et al., "P53 GENE-MUTATIONS ARE ASSOCIATED WITH DECREASED SENSITIVITY OF HUMANLYMPHOMA-CELLS TO DNA-DAMAGING AGENTS", Cancer research, 54(22), 1994, pp. 5824-5830
46. WEINTRAUB M; ADDE M; SHAD A; HORAK I; SEIBEL N; NEELY J; MAGRATH I
    PROFOUND PERIPHERAL NEUROPATHY ASSOCIATED WITH THE ADMINISTRATION OF COLONY-STIMULATING FACTORS
    Blood
    
    M. Weintraub et al., "PROFOUND PERIPHERAL NEUROPATHY ASSOCIATED WITH THE ADMINISTRATION OF COLONY-STIMULATING FACTORS", Blood, 84(10), 1994, pp. 10000128-10000128
47. GREVER MR; BHATIA K; GIAVAZZI R; HOLLINGSHEAD M; MAGRATH I; MALSPEIS L; MAYO J; SHORES R
    EXPERIMENTAL THERAPEUTIC AGENTS IN AN AIDS-RELATED SCID MOUSE MODEL
    Blood
    
    M.R. Grever et al., "EXPERIMENTAL THERAPEUTIC AGENTS IN AN AIDS-RELATED SCID MOUSE MODEL", Blood, 84(10), 1994, pp. 10000447-10000447
48. FRANKLIN JL; NARESH KN; CACERES E; BHATIA K; OCONOR G; MAGRATH I
    P53 EXPRESSION, BCL-2 EXPRESSION AND EBV ASSOCIATION IN PERUVIAN NASAL LYMPHOMAS
    Blood
    
    J.L. Franklin et al., "P53 EXPRESSION, BCL-2 EXPRESSION AND EBV ASSOCIATION IN PERUVIAN NASAL LYMPHOMAS", Blood, 84(10), 1994, pp. 10000522-10000522
49. BHATIA K; HUPPI K; SPANGLER G; SIWARSKI D; IYER R; MAGRATH I
    POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS
    Nature genetics
    
    K. Bhatia et al., "POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS", Nature genetics, 5(1), 1993, pp. 56-61
50. BHATIA K; GOLDSCHMIDTS W; GUTIERREZ M; GAIDANO G; DALLAFAVERA R; MAGRATH I
    HEMIZYGOSITY OR HOMOZYGOSITY - A REQUIREMENT FOR SOME BUT NOT OTHER P53 MUTANT PROTEINS TO ACCUMULATE AND EXERT A PATHOGENETIC EFFECT
    The FASEB journal
    
    K. Bhatia et al., "HEMIZYGOSITY OR HOMOZYGOSITY - A REQUIREMENT FOR SOME BUT NOT OTHER P53 MUTANT PROTEINS TO ACCUMULATE AND EXERT A PATHOGENETIC EFFECT", The FASEB journal, 7(10), 1993, pp. 951-956
51. OCONNOR PM; JACKMAN J; JONDLE D; BHATIA K; MAGRATH I; KOHN KW
    ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN CELL-CYCLE ARREST AND RADIOSENSITIVITY OF BURKITTS-LYMPHOMA CELL-LINES
    Cancer research
    
    P.M. Oconnor et al., "ROLE OF THE P53 TUMOR-SUPPRESSOR GENE IN CELL-CYCLE ARREST AND RADIOSENSITIVITY OF BURKITTS-LYMPHOMA CELL-LINES", Cancer research, 53(20), 1993, pp. 4776-4780
52. SHAD A; ADDE M; MAGRATH I
    RESULTS OF NCI PROTOCOL 77-04 FOR TREATMENT OF LYMPHOBLASTIC LYMPHOMAIN CHILDREN
    Blood
    
    A. Shad et al., "RESULTS OF NCI PROTOCOL 77-04 FOR TREATMENT OF LYMPHOBLASTIC LYMPHOMAIN CHILDREN", Blood, 82(10), 1993, pp. 10000387-10000387
53. SHAD A; BHATIA K; HAMDY N; MUELLER B; PIZZO P; PENG JW; KNUTSEN T; JAFFE E; MAGRATH I
    MOLECULAR CHARACTERIZATION OF PEDIATRIC HIV-ASSOCIATED NON-HODGKINS-LYMPHOMAS
    Blood
    
    A. Shad et al., "MOLECULAR CHARACTERIZATION OF PEDIATRIC HIV-ASSOCIATED NON-HODGKINS-LYMPHOMAS", Blood, 82(10), 1993, pp. 10000578-10000578
54. MAGRATH I; LITVAK J
    CANCER IN DEVELOPING-COUNTRIES - OPPORTUNITY AND CHALLENGE
    Journal of the National Cancer Institute
    
    I. Magrath e J. Litvak, "CANCER IN DEVELOPING-COUNTRIES - OPPORTUNITY AND CHALLENGE", Journal of the National Cancer Institute, 85(11), 1993, pp. 862-874